Vitestro is advancing one of the most ambitious automation opportunities in diagnostics: autonomous robotic blood collection. Led by Co-Founder and CEO Toon Overbeeke, with commercial and strategic leadership from Bob Gerberich and Andy McGibbon, the company has moved from an early vision to a CE-marked platform backed by extensive clinical experience, strong patient preference data, and a $70 million oversubscribed Series B round that positions it for commercialization.
In 2017, Toon Overbeeke set out to answer a deceptively simple question: why hasn’t something as routine as blood drawing improved with technology?
That question was not theoretical. It was rooted in lived experience. A close friend’s father endured repeated failed punctures during chemotherapy. Co-founder Brian Joseph saw similar challenges when one of his children needed frequent blood draws. What should have been routine became painful, inconsistent, and deeply frustrating.
“We eliminate variability by standardizing the entire procedure, which has proven to be a significant benefit for patients,” said Overbeeke.
Nearly a decade later, that early insight has evolved into a fully realized platform. Vitestro’s Aletta Autonomous Robotic Phlebotomy Device is now CE-marked in Europe and represents the world’s first autonomous robotic approach to diagnostic blood collection.
Despite its ubiquity, it remains one of the most overlooked and under-optimized processes in modern medicine.
The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry. The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry.
The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry. The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry.
The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry. The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry.
The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry.
The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry.
The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry.
The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry. The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry. The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry.
17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2026 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy | Your Privacy Choices | Delete my Data